Xtant Medical Holdings, Inc. Reports Third Quarter 2015 Results
11 nov. 2015 16h27 HE
|
Xtant Medical Holdings, Inc.
Third Quarter 2015 Consolidated Pro Forma Highlights: Consolidated pro forma revenue increased 6.5% to $20.9 million from $19.6 million in the third quarter of 2014. Excluding OEM revenue,...
Xtant Announces Preliminary Third Quarter 2015 Revenue
13 oct. 2015 07h30 HE
|
Xtant Medical Holdings, Inc.
Third Quarter 2015 Pro Forma Combined Revenue in the range of $20.7 million to $20.9 million, an increase of 5.5 % to 6.5 % over the same period last yearExcluding OEM Revenue, Third Quarter 2015...
Xtant(TM) Medical Exhibits at North American Spine Society (NASS) Meeting
12 oct. 2015 13h13 HE
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative medicine products and medical devices, today announced...